Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal leishmaniasis refractory to antimony: a case report



Título del documento: Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal leishmaniasis refractory to antimony: a case report
Revista: The brazilian journal of infectious diseases
Base de datos: PERIÓDICA
Número de sistema: 000290644
ISSN: 1413-8670
Autores: 1





Instituciones: 1Hospital Universitario Prof. Edgar Santos, Unidade Docente Assistencial de Infectologia, Salvador, Bahia. Brasil
Año:
Periodo: Ago
Volumen: 5
Número: 4
Paginación: 223-232
País: Brasil
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Experimental
Resumen en inglés Immunotherapy has been proposed as a method to treat mucosal leishmaniasis for many years, but the approach has been hampered by poor definition and variability of antigens used, and results have been inconclusive. We report here a case of antimonial-refractory mucosal leishmaniasis in a 45 year old male who was treated with three single injections (one per month) with a cocktail of four Leishmania recombinant antigens selected after documented hypo-responsiveness of the patient to these antigens, plus 50mg of GM-CSF as vaccine adjuvant. Three months after treatment, all lesions had resolved completely and the patient remains without relapse after two years. Side effects of the treatment included only moderate erythema and induration at the injection site after the second and third injections. We conclude that carefully selected microbial antigens and cytokine adjuvant can be successful as immunotherapy for patients with antimonial-refractory mucosal leishmaniasis
Disciplinas: Medicina,
Biología
Palabras clave: Terapéutica y rehabilitación,
Inmunología,
Parasitología,
Leishmaniasis,
Inmunoterapia,
Leishmaniasis mucosa
Keyword: Medicine,
Biology,
Therapeutics and rehabilitation,
Immunology,
Parasitology,
Leishmaniasis,
Immunotherapy,
Mucosal leishmaniasis
Texto completo: Texto completo (Ver HTML)